Dupilumab treatment of severe uncontrolled CRSwNP: Real life data of 2 years of treatment

Mathias Heidemann, Marius Thalau, S Jeschke,Robert Böscke,Karl‐Ludwig Bruchhage

Laryngo-rhino-otologie（2023）

引用 0|浏览2

暂无评分

摘要

Background Dupilumab was the first biological drug to be approved for the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

查看译文

关键词

severe uncontrolled crswnp,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要